Odyssey Health (ODYY) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Odyssey Health | - | - | - | 82.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 82.13% |
| Oct 31, 2025 | 62.25% |
| Jul 31, 2025 | -193.26% |
| Apr 30, 2025 | 42.29% |
| Jan 31, 2025 | 69.80% |
| Oct 31, 2024 | -363.04% |
| Jul 31, 2024 | 168.85% |
| Apr 30, 2024 | 36.97% |
| Jan 31, 2024 | -6.78% |
| Oct 31, 2023 | 93.76% |
| Jul 31, 2023 | 60.09% |
| Apr 30, 2023 | 53.09% |
| Jan 31, 2023 | 19.12% |
| Oct 31, 2022 | -342.16% |
| Jul 31, 2022 | -16.00% |
| Apr 30, 2022 | 63.60% |
| Jan 31, 2022 | -251.70% |
| Oct 31, 2021 | -133.68% |
| Jul 31, 2021 | -34.92% |
| Apr 30, 2021 | -413.33% |
| Jan 31, 2021 | 45.51% |
| Oct 31, 2020 | 79.98% |
| Jul 31, 2020 | 99.47% |
| Apr 30, 2020 | -156.48% |
| Jan 31, 2020 | 8.07% |
| Oct 31, 2019 | -359.49% |
| Jul 31, 2019 | -25,795.11% |
| Apr 30, 2019 | 27.60% |
| Jan 31, 2019 | 64.12% |
| Oct 31, 2018 | 13.83% |
| Jul 31, 2018 | -3.68% |
| Apr 30, 2018 | 62.66% |
| Jan 31, 2018 | -195.86% |
| Oct 31, 2017 | -33.32% |
| Jul 31, 2017 | 13.68% |
| Apr 30, 2017 | -1,440.12% |
| Jan 31, 2017 | 53.03% |
| Oct 31, 2016 | 96.64% |
| Jul 31, 2016 | 97.55% |
| Apr 30, 2016 | 99.84% |
| Jan 31, 2016 | 74.18% |
| Oct 31, 2015 | -572.00% |